Cerena Chen
Stock Analyst at Wells Fargo
(2.80)
# 1,687
Out of 5,134 analysts
5
Total ratings
100%
Success rate
39.06%
Average return
Main Sectors:
Stocks Rated by Cerena Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MSTR Strategy | Downgrades: Equal-Weight | $65 → $54 | $133.88 | -59.67% | 1 | Sep 30, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Overweight | $40 → $35 | $28.48 | +22.89% | 1 | May 8, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Overweight | $160 → $165 | $181.21 | -8.95% | 3 | May 6, 2025 |
Strategy
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $65 → $54
Current: $133.88
Upside: -59.67%
Amphastar Pharmaceuticals
May 8, 2025
Maintains: Overweight
Price Target: $40 → $35
Current: $28.48
Upside: +22.89%
Axsome Therapeutics
May 6, 2025
Maintains: Overweight
Price Target: $160 → $165
Current: $181.21
Upside: -8.95%